These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7864812)

  • 1. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
    Harada S; Smith RM; Smith JA; Shah N; Jarett L
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway.
    Harada S; Smith RM; Smith JA; Jarett L
    Endocrinology; 1993 Jun; 132(6):2293-8. PubMed ID: 8504733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone inhibits insulin binding to insulin-degrading enzyme and cytosolic insulin-binding protein p82.
    Harada S; Smith RM; Hu DQ; Jarett L
    Biochem Biophys Res Commun; 1996 Jan; 218(1):154-8. PubMed ID: 8573122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a 65 kDa ras binding protein in rat and sheep brain cytosol using a chemical cross linking agent.
    Chataway TK; Barritt GJ
    Mol Cell Biochem; 1995 Apr; 145(2):111-20. PubMed ID: 7675031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells.
    Authier F; Cameron PH; Taupin V
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):149-58. PubMed ID: 8870662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver.
    Wroblewski VJ; Masnyk M; Khambatta SS; Becker GW
    Diabetes; 1992 Apr; 41(4):539-47. PubMed ID: 1607078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody.
    Hari J; Shii K; Roth RA
    Endocrinology; 1987 Feb; 120(2):829-31. PubMed ID: 3026782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
    Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific distribution of cross-linked somatostatin receptor proteins in the rat.
    Srikant CB; Murthy KK; Patel YC
    Biochem J; 1992 Mar; 282 ( Pt 2)(Pt 2):339-44. PubMed ID: 1312325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked Nanogold-insulin.
    Shah N; Zhang S; Harada S; Smith RM; Jarett L
    Endocrinology; 1995 Jul; 136(7):2825-35. PubMed ID: 7789307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
    Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K
    J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
    Shii K; Baba S; Yokono K; Roth RA
    J Biol Chem; 1985 Jun; 260(11):6503-6. PubMed ID: 3888982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.
    Bai JP; Chang LL
    Pharm Res; 1995 Aug; 12(8):1171-5. PubMed ID: 7494830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
    Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
    Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of insulin binding to H35 hepatoma cells.
    de Vries CP; Van der Veen EA
    Biochimie; 1985; 67(10-11):1191-4. PubMed ID: 3907721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor regulation and desensitization in rat hepatoma cells. The loss of the oligomeric forms of the receptor correlates with the change in receptor affinity.
    Crettaz M; Jialal I; Kasuga M; Kahn CR
    J Biol Chem; 1984 Sep; 259(18):11543-9. PubMed ID: 6381501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity thyroid hormone-binding protein in human kidney: kinetic characterization and identification by photoaffinity labeling.
    Vié MP; Blanchet P; Samson M; Francon J; Blondeau JP
    Endocrinology; 1996 Nov; 137(11):4563-70. PubMed ID: 8895318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.
    Sturm MA; Conover CA; Pham H; Rosenfeld RG
    Endocrinology; 1989 Jan; 124(1):388-96. PubMed ID: 2462492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pig serum contains a specific high affinity growth hormone-binding protein with novel ligand specificity.
    Ymer SI; Stevenson JL; Herington AC
    Endocrinology; 1997 Sep; 138(9):3577-86. PubMed ID: 9275038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.